• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans
  • .org
  • Districts
  • Media
  • SupportUs
  • Collaborate
  • Contact
  • Search
  • Join


Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.


Photo

David Sinclair to co-chair $200 million biotech SPAC

Started by Oakman , Mar 19 2021 03:10 PM
longevity sinclair biotech harvard attia spac

  • Please log in to reply
2 replies to this topic

#1 Oakman

  • Location:CO

Posted 19 March 2021 - 03:10 PM


Christian Angermayer’s Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board.

https://longevity.te...xI9IvMUtELOlbiE


  • Informative x 1

#2 TranscendingSingularity

  • Guest
  • 26 posts
  • 3 ₮
  • Location:Sofia

Posted 30 March 2021 - 12:48 PM

I'm not at all a fan of Sinclair. It appears that the guy has no idea at all about the aging process, and just consistently pushes SIRT activators


#3 Oakman

  • Topic Starter
  • Guest
  • 1,221 posts
  • 1,566 ₮
  • Location:CO

Posted 30 March 2021 - 03:59 PM

He's interesting, gets a lot of publicity, but often I wonder about him as well.


sponsored ad

  • Advert
Back to Ventures & Markets



Also tagged with one or more of these keywords: longevity, sinclair, biotech, harvard, attia, spac

4 user(s) are reading this topic

0 members, 4 guests, 0 anonymous users

  1. LONGECITY
  2. → Round Table Discussion
  3. → Business
  4. → Ventures & Markets
  5. site rules